WT Business Beat

By Nick Wakeman

Blog archive
Nick Wakeman

CACI faces incumbent challenge over $445.9M contract

CACI International is facing a challenge from an unhappy incumbent that lost a $445.9 million contract to the Arlington, Va., company.

CACI was in the running for the contract to support the Air Force Satellite Control Network thanks to its acquisition of L-3 Communication’s National Security Solutions, which closed earlier this year.

The Air Force is consolidating three contracts into one, and Honeywell Technology Solutions was an incumbent on one of the expiring contracts. It filed a protest this week objecting to CACI’s winning.

No word yet on the other two incumbents – Harris Corp. and Lockheed Martin. We’ll follow the GAO docket to see when and if they file their own protests.

CACI acquired L-3’s NSS in February as part of a move to expand its capabilities and customer base, particularly for classified work, which the Air Force contract is. This win is an early success for the $550 million acquisition.

The new Air Force contract consolidates three existing ones: the Satellite Control Network, the Network and Space Operations Maintenance contract and the Engineering, Development and Sustainment contract.

The Air Force is combining them to create the Consolidated Air Force Satellite Control Network Modifications Maintenance Operations contract or AFSCN CAMMO. A variety of services will be acquired under the contract including factory capability testing, operations support, remote site support, sustainment and modifications.

Honeywell filed its protest June 27. A decision from GAO is expected Oct. 5.

Posted by Nick Wakeman on Jun 29, 2016 at 9:29 AM

Reader Comments

Please post your comments here. Comments are moderated, so they may not appear immediately after submitting. We will not post comments that we consider abusive or off-topic.

Please type the letters/numbers you see above.

WT Daily

Sign up for our newsletter.

Terms and Privacy Policy consent

I agree to this site's Privacy Policy.